Abstract
Peripheral neuropathy is a common neurological disorder that can be associated with a wide range of conditions, including rheumatic disease. Although the association of the two disorders can be coincidental, an underlying pathogenic link can occur in many instances, which can affect treatment options. The presentation of peripheral neuropathy can be multifaceted, an important consideration when recognizing the condition and optimizing diagnosis. Furthermore, understanding the diagnostic strategy will help physicians treating patients with rheumatic disease who develop peripheral neuropathy. Finally, although available treatment options have greatly reduced the risk of patients with inflammatory disorders developing systemic complications, among which includes peripheral neuropathy, new therapeutic agents can trigger toxic or immune-mediated neuropathies and treatment will need to be adjusted accordingly. In this Review, we will discuss the general approach for diagnosing patients with peripheral neuropathy, and detail the presentation, pathophysiological features and general rules of treatment of patients with peripheral neuropathy in the context of rheumatic disease.
Key Points
-
Peripheral neuropathy is frequently seen in patients with rheumatic disease, but extensive epidemiological data are lacking
-
The first steps in the diagnostic strategy of peripheral neuropathy include a detailed history, a careful clinical evaluation and complete electrodiagnostic tests
-
The causal link between peripheral neuropathy and rheumatic disease mainly includes compression by joint deformation or swelling, vasculitis or drug toxicity
-
The relationship between the two disorders is incompletely understood in many situations, as is the case, for example, for most of the peripheral neuropathies associated with rheumatoid arthritis, systemic lupus erythematosus and Sjögren's syndrome
-
The care of patients with this combination of disorders necessitates a multidisciplinary approach
-
Nerve and/or muscle biopsy might be necessary to understand the mechanism of peripheral nerve involvement in many patients with rheumatic disease; skin biopsy can be helpful to confirm the diagnosis of small-fibre neuropathy
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Agarwal, V. et al. A clinical, electrophysiological, and pathological study of neuropathy in rheumatoid arthritis. Clin. Rheumatol. 27, 841–844 (2008).
Schröder, J. M. Pathology of Peripheral Nerves: An Atlas of Structural and Molecular Pathological Changes (Springer Verlag, Berlin Heidelberg New York, 2001).
Vital, C. & Vallat, J. M. Ultrastructural Study of the Human Diseased Peripheral Nerve (Elsevier, New York, 1987).
de Waegh, S. M., Lee, V. M. & Brady, S. T. Local modulation of neurofilament phosphorylation, axonal caliber, and slow axonal transport by myelinating Schwann cells. Cell 68, 451–463 (1992).
Dyck, P. J., Grant, I. A. & Fealey, R. D. Ten steps in characterizing and diagnosing patients with peripheral neuropathy. Neurology 47, 10–17 (1996).
Albers, J. W. & Kelly, J. J. Jr Acquired inflammatory demyelinating polyneuropathies: clinical and electrodiagnostic features. Muscle Nerve 12, 435–451 (1989).
Titulaer, M. J. et al. Screening for tumours in paraneoplastic syndromes: report of an EFNS task force. Eur. J. Neurol. 18, 19-e3 (2011).
Vallat, J. M., Vital, A., Magy, L., Martin-Negrier, M. L. & Vital, C. An update on nerve biopsy. J. Neuropathol. Exp. Neurol. 68, 833–844 (2009).
Vallat, J. M., Funalot, B. & Magy, L. Nerve biopsy: requirements for diagnosis and clinical value. Acta Neuropathol. 121, 313–326 (2011).
Sommer, C. L. et al. Peripheral Nerve Society Guideline on processing and evaluation of nerve biopsies. J. Peripher. Nerv. Syst. 15, 164–175 (2010).
Magy, L. & Vallat, J. M. Nerve biopsy without muscle sampling: is it enough for diagnosing vasculitis? J. Neurol. Neurosurg. Psychiatry 79, 1307 (2008).
Vital, C. et al. Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy. A 16-year retrospective study of 202 cases. J. Peripher. Nerv. Syst. 11, 20–29 (2006).
England, J. D. et al. Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve 39, 106–115 (2009).
Lauria, G. et al. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur. J. Neurol. 17, 903–912 (2010).
Tseng, M. T. et al. Skin denervation and cutaneous vasculitis in systemic lupus erythematosus. Brain 129, 977–985 (2006).
Uceyler, N., Devigili, G., Toyka, K. V. & Sommer, C. Skin biopsy as an additional diagnostic tool in non-systemic vasculitic neuropathy. Acta Neuropathol. 120, 109–116 (2010).
Koroschetz, J. et al. Fibromyalgia and neuropathic pain—differences and similarities. A comparison of 3057 patients with diabetic painful neuropathy and fibromyalgia. BMC Neurol. 11, 55 (2011).
Bouhassira, D. et al. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). Pain 114, 29–36 (2005).
Sofat, N., Malik, O. & Higgens, C. S. Neurological involvement in patients with rheumatic disease. QJM 99, 69–79 (2006).
Lanzillo, B. et al. Subclinical peripheral nerve involvement in patients with rheumatoid arthritis. Arthritis Rheum. 41, 1196–1202 (1998).
Mori, K. et al. The wide spectrum of clinical manifestations in Sjogren's syndrome-associated neuropathy. Brain 128, 2518–2534 (2005).
Harboe, E. et al. Neuropsychiatric syndromes in patients with systemic lupus erythematosus and primary Sjogren syndrome: a comparative population-based study. Ann. Rheum. Dis. 68, 1541–1546 (2009).
Sene, D. et al. Peripheral neuropathies associated with primary Sjogren syndrome: immunologic profiles of nonataxic sensory neuropathy and sensorimotor neuropathy. Medicine (Baltimore) 90, 133–138 (2011).
Pavlakis, P. P. et al. Peripheral neuropathies in Sjogren syndrome: a new reappraisal. J. Neurol. Neurosurg. Psychiatry 82, 798–802 (2011).
[No authors listed] The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 42, 599–608 (1999).
Florica, B. et al. Peripheral neuropathy in patients with systemic lupus erythematosus. Semin. Arthritis Rheum. 41, 203–211 (2011).
Rowbotham, M. C. Is fibromyalgia a neuropathic pain syndrome? J. Rheumatol. Suppl. 75, 38–40 (2005).
Caro, X. J., Winter, E. F. & Dumas, A. J. A subset of fibromyalgia patients have findings suggestive of chronic inflammatory demyelinating polyneuropathy and appear to respond to IVIg. Rheumatology (Oxford) 47, 208–211 (2008).
Collins, M. P. et al. Superficial peroneal nerve/peroneus brevis muscle biopsy in vasculitic neuropathy. Neurology 55, 636–643 (2000).
Guillevin, L. et al. Hepatitis B virus-associated polyarteritis nodosa: clinical characteristics, outcome, and impact of treatment in 115 patients. Medicine (Baltimore) 84, 313–322 (2005).
Said, G., Lacroix-Ciaudo, C., Fujimura, H., Blas, C. & Faux, N. The peripheral neuropathy of necrotizing arteritis: a clinicopathological study. Ann. Neurol. 23, 461–465 (1988).
Hattori, N. et al. Clinicopathological features of Churg-Strauss syndrome-associated neuropathy. Brain 122 (Pt 3), 427–439 (1999).
Cattaneo, L. et al. Peripheral neuropathy in Wegener's granulomatosis, Churg–Strauss syndrome and microscopic polyangiitis. J. Neurol. Neurosurg. Psychiatry 78, 1119–1123 (2007).
Sugiura, M. et al. Clinicopathologic features of nonsystemic vasculitic neuropathy and microscopic polyangiitis-associated neuropathy: a comparative study. J. Neurol. Sci. 241, 31–37 (2006).
Seo, J. H., Ryan, H. F., Claussen, G. C., Thomas, T. D. & Oh, S. J. Sensory neuropathy in vasculitis: a clinical, pathologic, and electrophysiologic study. Neurology 63, 874–878 (2004).
Said, G. et al. Nerve granulomas and vasculitis in sarcoid peripheral neuropathy: a clinicopathological study of 11 patients. Brain 125, 264–275 (2002).
Suppiah, R. et al. Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials. Rheumatology (Oxford) 50, 2214–2222 (2011).
Walsh, M. et al. Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Care Res. (Hoboken) 63, 1055–1061 (2011).
Cacoub, P. et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. Medicine (Baltimore) 79, 47–56 (2000).
Ramos-Casals, M., Stone, J. H., Cid, M. C. & Bosch, X. The cryoglobulinaemias. Lancet 379, 348–360 (2012).
Taieb, G. et al. Cryoglobulinemic peripheral neuropathy in hepatitis C virus infection: clinical and anatomical correlations of 22 cases [French]. Rev. Neurol. (Paris) 166, 509–514 (2010).
Griffin, J. W. et al. Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjogren's syndrome. Ann. Neurol. 27, 304–315 (1990).
Burgdorfer, W. Discovery of the Lyme disease spirochete and its relation to tick vectors. Yale J. Biol. Med. 57, 515–520 (1984).
Steere, A. C. et al. Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three connecticut communities. Arthritis Rheum. 20, 7–17 (1977).
Stanek, G., Wormser, G. P., Gray, J. & Strle, F. Lyme borreliosis. Lancet 379, 461–473 (2012).
Bhate, C. & Schwartz, R. A. Lyme disease: Part I. Advances and perspectives. J. Am. Acad. Dermatol. 64, 619–636; quiz 637–638 (2011).
Vallat, J. M. et al. Tick-bite meningoradiculoneuritis: clinical, electrophysiologic, and histologic findings in 10 cases. Neurology 37, 749–753 (1987).
Schafers, M., Neukirchen, S., Toyka, K. V. & Sommer, C. Diagnostic value of sural nerve biopsy in patients with suspected Borrelia neuropathy. J. Peripher. Nerv. Syst. 13, 81–91 (2008).
Suzuki, K. et al. Current status of leprosy: epidemiology, basic science and clinical perspectives. J. Dermatol. 39, 121–129 (2012).
Lacomis, D. Small-fiber neuropathy. Muscle Nerve 26, 173–188 (2002).
Devigili, G. et al. The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology. Brain 131, 1912–1925 (2008).
Gorson, K. C. et al. Non-length dependent small fibre neuropathy/ganglionopathy. J. Neurol. Neurosurg. Psychiatry 79, 163–169 (2008).
Hoitsma, E. et al. Small fibre neuropathy in sarcoidosis. Lancet 359, 2085–2086 (2002).
Brannagan, T. H., 3rd. et al. Small-fiber neuropathy/neuronopathy associated with celiac disease: skin biopsy findings. Arch. Neurol. 62, 1574–1578 (2005).
Goransson, L. G., Brun, J. G., Harboe, E., Mellgren, S. I. & Omdal, R. Intraepidermal nerve fiber densities in chronic inflammatory autoimmune diseases. Arch. Neurol. 63, 1410–1413 (2006).
Chai, J. & Logigian, E. L. Neurological manifestations of primary Sjogren's syndrome. Curr. Opin. Neurol. 23, 509–513 (2010).
Gemignani, F. et al. Non-length dependent small fiber neuropathy. a prospective case series. J. Peripher. Nerv. Syst. 15, 57–62 (2010).
Khan, S. & Zhou, L. Characterization of non-length-dependent small-fiber sensory neuropathy. Muscle Nerve 45, 86–91 (2012).
Cesarini, M., Angelucci, E., Foglietta, T. & Vernia, P. Guillain-Barre syndrome after treatment with human anti-tumor necrosis factoralpha (adalimumab) in a Crohn's disease patient: case report and literature review. J. Crohns Colitis 5, 619–622 (2011).
Shin, I. S., Baer, A. N., Kwon, H. J., Papadopoulos, E. J. & Siegel, J. N. Guillain–Barre and Miller Fisher syndromes occurring with tumor necrosis factor alpha antagonist therapy. Arthritis Rheum. 54, 1429–1434 (2006).
Stubgen, J. P. Tumor necrosis factor-alpha antagonists and neuropathy. Muscle Nerve 37, 281–292 (2008).
Lozeron, P., Denier, C., Lacroix, C. & Adams, D. Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy. Arch. Neurol. 66, 490–497 (2009).
Richards, B. L. et al. Effect of leflunomide on the peripheral nerves in rheumatoid arthritis. Intern. Med. J. 37, 101–107 (2007).
Alcorn, N., Saunders, S. & Madhok, R. Benefit-risk assessment of leflunomide: an appraisal of leflunomide in rheumatoid arthritis 10 years after licensing. Drug Saf. 32, 1123–1134 (2009).
Martin, K. et al. Neuropathy associated with leflunomide: a case series. Ann. Rheum. Dis. 64, 649–650 (2005).
Gabelle, A., Antoine, J. C., Hillaire-Buys, D., Coudeyre, E. & Camu, W. Leflunomide-related severe axonal neuropathy [French]. Rev. Neurol. (Paris) 161, 1106–1109 (2005).
Kelly, J. J. Jr Peripheral neuropathies associated with monoclonal proteins: a clinical review. Muscle Nerve 8, 138–150 (1985).
Dispenzieri, A. POEMS syndrome: 2011 update on diagnosis, risk-stratification, and management. Am. J. Hematol. 86, 591–601 (2011).
Vallat, J. M. et al. Intranervous immunoglobulin deposits: an underestimated mechanism of neuropathy. Muscle Nerve 38, 904–911 (2008).
Kawagashira, Y. et al. Morphological progression of myelin abnormalities in IgM-monoclonal gammopathy of undetermined significance anti-myelin-associated glycoprotein neuropathy. J. Neuropathol. Exp. Neurol. 69, 1143–1157 (2010).
Vallat, J. M., Magy, L., Sindou, P., Magdelaine, C. & Cros, D. IgG neuropathy: an immunoelectron microscopic study. J. Neuropathol. Exp. Neurol. 64, 386–390 (2005).
Vallat, J. M. et al. Myelin widenings and MGUS-IgA: an immunoelectron microscopic study. Ann. Neurol. 47, 808–811 (2000).
Vallat, J. M., Sommer, C. & Magy, L. Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition. Lancet Neurol. 9, 402–412 (2010).
Dyck, P. J. et al. Chronic inflammatory polyradiculoneuropathy. Mayo Clin. Proc. 50, 621–637 (1975).
Joint Task Force of the EFNS & the PNS. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society—First Revision. J. Peripher. Nerv. Syst. 15, 1–9 (2010).
Lewis, R. A., Sumner, A. J., Brown, M. J. & Asbury, A. K. Multifocal demyelinating neuropathy with persistent conduction block. Neurology 32, 958–964 (1982).
Oh, S. J. et al. Multifocal motor sensory demyelinating neuropathy: inflammatory demyelinating polyradiculoneuropathy. Neurology 65, 1639–1642 (2005).
Magy, L. & Vallat, J. M. Evidence-based treatment of chronic immune-mediated neuropathies. Expert Opin. Pharmacother. 10, 1741–1754 (2009).
Geoghegan, J. M., Clark, D. I., Bainbridge, L. C., Smith, C. & Hubbard, R. Risk factors in carpal tunnel syndrome. J. Hand Surg. Br. 29, 315–320 (2004).
Sivri, A. & Guler-Uysal, F. The electroneurophysiological findings in rheumatoid arthritis patients. Electromyogr. Clin. Neurophysiol. 39, 387–391 (1999).
Muramatsu, K., Tanaka, H. & Taguchi, T. Peripheral neuropathies of the forearm and hand in rheumatoid arthritis: diagnosis and options for treatment. Rheumatol. Int. 28, 951–957 (2008).
Matsuda, M. et al. Peripheral nerve involvement in primary systemic AL amyloidosis: a clinical and electrophysiological study. Eur. J. Neurol. 18, 604–610 (2011).
Kiuru, S. & Seppalainen, A. M. Neuropathy in familial amyloidosis, Finnish type (FAF): electrophysiological studies. Muscle & Nerve 17, 299–304 (1994).
Otsubo, S. et al. Characteristics of dialysis-related amyloidosis in patients on haemodialysis therapy for more than 30 years. Nephrol. Dial. Transplant. 24, 1593–1598 (2009).
Malipeddi, A., Reddy, V. R. & Kallarackal, G. Posterior interosseous nerve palsy: an unusual complication of rheumatoid arthritis: case report and review of the literature. Semin. Arthritis Rheum. 40, 576–579 (2011).
Chance, P. F. Inherited focal, episodic neuropathies: hereditary neuropathy with liability to pressure palsies and hereditary neuralgic amyotrophy. Neuromolecular Med. 8, 159–174 (2006).
Hong, Y. H. et al. Clinical and electrophysiologic features of HNPP patients with 17p11.2 deletion. Acta Neurol. Scand. 108, 352–358 (2003).
Vallat, J. M. Dominantly inherited peripheral neuropathies. J. Neuropathol. Exp. Neurol. 62, 699–714 (2003).
Charcot, J. Sur quelques arthropathies qui paraissent dépendre d'une lésion du cerveau ou de la moelle épinière [French]. Arch. Physiol. Norm. et Pathol. 1, 161–178 (1868).
Kucera, T., Urban, K. & Sponer, P. Charcot arthropathy of the knee. A case-based review. Clin. Rheumatol. 30, 425–428 (2011).
Dogan, B. E., Sahin, G., Yagmurlu, B. & Erden, I. Neuroarthropathy of the extremities: magnetic resonance imaging features. Curr. Probl. Diagn. Radiol. 32, 227–232 (2003).
Botek, G., Anderson, M. A. & Taylor, R. Charcot neuroarthropathy: an often overlooked complication of diabetes. Cleve. Clin. J. Med. 77, 593–599 (2010).
Reilly, M. M., Murphy, S. M. & Laura, M. Charcot–Marie–Tooth disease. J. Peripher. Nerv. Syst. 16, 1–14 (2011).
Pareyson, D. & Marchesi, C. Diagnosis, natural history, and management of Charcot–Marie–Tooth disease. Lancet Neurol. 8, 654–667 (2009).
Pareyson, D., Scaioli, V. & Laura, M. Clinical and electrophysiological aspects of Charcott–Marie–Tooth disease. Neuromolecular Med. 8, 3–22 (2006).
Auer-Grumbach, M. et al. Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C. Nat. Genet. 42, 160–164 (2010).
Camdessanche, J. P. et al. The pattern and diagnostic criteria of sensory neuronopathy: a case–control study. Brain 132, 1723–1733 (2009).
Berden, A. et al. Diagnosis and management of ANCA associated vasculitis. BMJ 344, e26 (2012).
Langford, C. A. Vasculitis. J. Allergy Clin. Immunol. 125, S216–S225 (2010).
Baughman, R. P. & Nunes, H. Therapy for sarcoidosis: evidence-based recommendations. Expert Rev. Clin. Immunol. 8, 95–103 (2012).
Birnbaum, J. Peripheral nervous system manifestations of Sjogren syndrome: clinical patterns, diagnostic paradigms, etiopathogenesis, and therapeutic strategies. Neurologist 16, 287–297 (2010).
Gorson, K. C., Natarajan, N., Ropper, A. H. & Weinstein, R. Rituximab treatment in patients with IVIg-dependent immune polyneuropathy: a prospective pilot trial. Muscle Nerve 35, 66–69 (2007).
Carulli, M. T. & Davies, U. M. Peripheral neuropathy: an unwanted effect of leflunomide? Rheumatology (Oxford) 41, 952–953 (2002).
Alshekhlee, A., Basiri, K., Miles, J. D., Ahmad, S. A. & Katirji, B. Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists. Muscle Nerve 41, 723–727 (2010).
Parambil, J. G., Tavee, J. O., Zhou, L., Pearson, K. S. & Culver, D. A. Efficacy of intravenous immunoglobulin for small fiber neuropathy associated with sarcoidosis. Respir. Med. 105, 101–105 (2011).
Wakasugi, D. et al. Extreme efficacy of intravenous immunoglobulin therapy for severe burning pain in a patient with small fiber neuropathy associated with primary Sjogren's syndrome. Mod. Rheumatol. 19, 437–440 (2009).
Brannagan, T. H. 3rd. Current treatments of chronic immune-mediated demyelinating polyneuropathies. Muscle Nerve 39, 563–578 (2009).
Nobile-Orazio, E. Treatment of dys-immune neuropathies. J. Neurol. 252, 385–395 (2005).
Author information
Authors and Affiliations
Contributions
All authors made equal contributions to researching data for and writing this Review. J.-M. Vallat and L. Magy made equal contributions to discussion of content and reviewing and/or editing the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Vallat, JM., Rabin, M. & Magy, L. Peripheral neuropathies in rheumatic disease—a guide to diagnosis. Nat Rev Rheumatol 8, 599–609 (2012). https://doi.org/10.1038/nrrheum.2012.138
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrrheum.2012.138
This article is cited by
-
Advances in imaging technologies for the assessment of peripheral neuropathies in rheumatoid arthritis
Rheumatology International (2021)
-
Periphere Nervenbeteiligung bei rheumatischen Erkrankungen
Zeitschrift für Rheumatologie (2019)
-
Bilateral facial paralysis as a rare neurological manifestation of primary Sjögren’s syndrome: case-based review
Rheumatology International (2019)